spacer
home > pmps > spring 2019 > pharmaceutical fraud
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Pharmaceutical Fraud

In 2011, a man was jailed for eight years for conducting counterfeit medicine fraud that amounted to a retail value of £4.7 million. As a result of him being able to infiltrate the pharmaceutical supply chain, 25,000 packets of counterfeit medication reached pharmacies and patients all over the UK. These knock-off tablets were used to treat heart disease, pancreatic cancer, and mental illnesses and had none, or only part, of the active ingredient they were supposed to contain. Sadly, this meant that those people’s illnesses were left to take their course.

Unfortunately, while tremendous effort goes into ensuring the effective operation of every pharma supply chain, the losses are staggering. With the global counterfeit drug market worth £154 billion and one million people dying due to fake medicine around the world each year, a reliable supply chain is paramount. Enter: blockchain. While blockchain harnesses a plethora of benefits, addressing its shortcomings is necessary to ensure that implementation of the technology can be utilised to its full effect.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Karim Jawhary is the Senior Industry Director of Life Sciences and Healthcare at Unisys. He brings over 15 years’ experience to the technology industry, with deep expertise in cloud computing, Software-as-a- Service, Big Data, and security solutions. Prior to joining Unisys, Karim served at TIBCO Software as a Senior Account Executive, leveraging the TIBCO connected intelligence cloud to augment business intelligence and agility through analytical insights. He also worked at Akamai Technologies as an Enterprise Account Executive where he built a strong life sciences and healthcare practice. Karim holds a bachelor’s degree in business management from East Stroudsburg University of Pennsylvania, US, and has pursued continuing education in force management, Miller Heiman strategic selling, and Sales Performance International solution selling.
spacer
Karim Jawhary
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

A new anti-tumour treatment is one step closer to the clinic thanks to a new collaboration between In3Bio and 3P Biopharmaceuticals

[Pamplona, November 26 2019] 3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has been chosen by In3Bio, a UK based Biotech company, to collaborate in the development of a novel anti-tumour treatment.
More info >>

White Papers

Advantages of Quantitative NMR for the Determination of Relative Response Factors

Novatia, LLC

Quantitative NMR (qNMR) is a technique that is being applied broadly and at an increasing rate in the field of pharmaceutical analysis (1). This white paper highlights the advantages of using qNMR to determine Relative Response Factors (RRFs) for pharmaceutical impurities detectable by HPLC. A single determination of RRFs using qNMR allows for simple and accurate quantitation of impurities which eliminates the need for preparation, qualification, and storage of reference standards. An example is presented here, which demonstrates quantitation of known impurities that have variable responses to UV-VIS detection, thereby providing a more accurate assessment of impurity levels than UV-VIS response alone.
More info >>

 
Industry Events

INTERPHEX 2020

15-17 July 2020, Javits Center NYC


More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement